TY - JOUR
T1 - Flanking base effects on the structural conformation of the (+)-trans-anti-benzo[α]pyrene diolepoxide adduct to N-dg in sequence-defined oligonucleotides
AU - Suh, Myungkoo
AU - Jankowiak, R.
AU - Ariese, F.
AU - Mao, B.
AU - Geacintov, Nicholas E.
AU - Small, Gerald J.
PY - 1994/12
Y1 - 1994/12
N2 - Conformations of the trans adduct of (+)-anti-benzo[a]8- pyrene -7,8-dihydrodiol-9,10-epoxide (BPDE) to N2-guanine, the major stable DNA adduct of the environmental carcinogen benzo[a]pyrene, were studied as a function of flanking bases in single-stranded and in double-stranded oligonucleotides. Three llmer oligonucleotides d(CTATG1G2G3TATC) were synthesized containing the (+)-transanti-BPDE adduct at one specific guanine of the GGG sequence (a known mutational hot spot). Polyacrylamide gel electrophoresis of the three single-stranded oligonucleotides showed that the adduct bound to G2 or G3 (5'-flanking base guanine) caused significantly stronger retardation than the same adduct bound to Gt (5'-flanking base thymine). The strength of the carcinogen-base interaction was reflected in the spectroscopic properties of the pyrenyl moiety. Low temperature fluorescence measurements under line-narrowing (FLN) or non-line-narrowing (NLN) conditions showed that in single-stranded form the adduct at G2 or G3 (5'-flanking base guanine) adopts a conformation with strong interaction with the bases. This was also observed for the same adduct at the sequence AGA. In contrast, the (+)-trans-anti-BPDE adduct with a 5' -flanking thymine exists in a primarily helix-external conformation. Similar differences were observed in the double-stranded oligonucleotides: the adducts at G2 and G3 were found to exist in similar conformational equilibria, again with significant carcinogen-base interactions, while the adduct at G1 showed a predominantly external conformation. The nature of the 3'-flanking base appeared to have little influence on the conformational equilibrium of the (+)-trans-anti-BTDE-guanine adduct The results could provide insight into the mutational specificity and flanking base effects observed for (+)-anti-BPDE.
AB - Conformations of the trans adduct of (+)-anti-benzo[a]8- pyrene -7,8-dihydrodiol-9,10-epoxide (BPDE) to N2-guanine, the major stable DNA adduct of the environmental carcinogen benzo[a]pyrene, were studied as a function of flanking bases in single-stranded and in double-stranded oligonucleotides. Three llmer oligonucleotides d(CTATG1G2G3TATC) were synthesized containing the (+)-transanti-BPDE adduct at one specific guanine of the GGG sequence (a known mutational hot spot). Polyacrylamide gel electrophoresis of the three single-stranded oligonucleotides showed that the adduct bound to G2 or G3 (5'-flanking base guanine) caused significantly stronger retardation than the same adduct bound to Gt (5'-flanking base thymine). The strength of the carcinogen-base interaction was reflected in the spectroscopic properties of the pyrenyl moiety. Low temperature fluorescence measurements under line-narrowing (FLN) or non-line-narrowing (NLN) conditions showed that in single-stranded form the adduct at G2 or G3 (5'-flanking base guanine) adopts a conformation with strong interaction with the bases. This was also observed for the same adduct at the sequence AGA. In contrast, the (+)-trans-anti-BPDE adduct with a 5' -flanking thymine exists in a primarily helix-external conformation. Similar differences were observed in the double-stranded oligonucleotides: the adducts at G2 and G3 were found to exist in similar conformational equilibria, again with significant carcinogen-base interactions, while the adduct at G1 showed a predominantly external conformation. The nature of the 3'-flanking base appeared to have little influence on the conformational equilibrium of the (+)-trans-anti-BTDE-guanine adduct The results could provide insight into the mutational specificity and flanking base effects observed for (+)-anti-BPDE.
UR - http://www.scopus.com/inward/record.url?scp=0028587329&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028587329&partnerID=8YFLogxK
U2 - 10.1093/carcin/15.12.2891
DO - 10.1093/carcin/15.12.2891
M3 - Article
C2 - 8001252
AN - SCOPUS:0028587329
VL - 15
SP - 2891
EP - 2898
JO - Carcinogenesis
JF - Carcinogenesis
SN - 0143-3334
IS - 12
ER -